EA200300770A1 - Антагонисты рецепторов возбуждающей аминокислоты - Google Patents
Антагонисты рецепторов возбуждающей аминокислотыInfo
- Publication number
- EA200300770A1 EA200300770A1 EA200300770A EA200300770A EA200300770A1 EA 200300770 A1 EA200300770 A1 EA 200300770A1 EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A EA200300770 A EA 200300770A EA 200300770 A1 EA200300770 A1 EA 200300770A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- formula
- excessing
- antagonists
- amino acid
- acid receptors
- Prior art date
Links
- 102000015404 Amino Acid Receptors Human genes 0.000 title 1
- 108010025177 Amino Acid Receptors Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200300770A1 true EA200300770A1 (ru) | 2003-10-30 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200300770A EA200300770A1 (ru) | 2001-01-05 | 2001-12-20 | Антагонисты рецепторов возбуждающей аминокислоты |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (enExample) |
| JP (1) | JP2004520335A (enExample) |
| KR (1) | KR20030066797A (enExample) |
| CN (1) | CN1484642A (enExample) |
| AR (1) | AR035679A1 (enExample) |
| BR (1) | BR0116672A (enExample) |
| CA (1) | CA2431545A1 (enExample) |
| CZ (1) | CZ20031856A3 (enExample) |
| DZ (1) | DZ3460A1 (enExample) |
| EA (1) | EA200300770A1 (enExample) |
| EC (1) | ECSP034682A (enExample) |
| HR (1) | HRP20030544A2 (enExample) |
| HU (1) | HUP0302528A2 (enExample) |
| IL (1) | IL156138A0 (enExample) |
| MX (1) | MXPA03005981A (enExample) |
| NO (1) | NO20032973D0 (enExample) |
| NZ (1) | NZ525821A (enExample) |
| PE (1) | PE20020792A1 (enExample) |
| PL (1) | PL361934A1 (enExample) |
| SK (1) | SK8242003A3 (enExample) |
| TW (1) | TW591023B (enExample) |
| WO (1) | WO2002053561A1 (enExample) |
| ZA (1) | ZA200304311B (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP1053234A1 (en) * | 1998-02-06 | 2000-11-22 | Smithkline Beecham Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DZ3209A1 (fr) * | 1999-07-06 | 2001-01-11 | Lilly Co Eli | Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine. |
-
2001
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL361934A1 (en) | 2004-10-18 |
| MXPA03005981A (es) | 2003-09-10 |
| WO2002053561A1 (en) | 2002-07-11 |
| BR0116672A (pt) | 2003-09-23 |
| CA2431545A1 (en) | 2002-07-11 |
| KR20030066797A (ko) | 2003-08-09 |
| PE20020792A1 (es) | 2002-09-06 |
| DZ3460A1 (fr) | 2002-07-11 |
| TW591023B (en) | 2004-06-11 |
| NO20032973L (no) | 2003-06-27 |
| HRP20030544A2 (en) | 2004-08-31 |
| ECSP034682A (es) | 2003-08-29 |
| ZA200304311B (en) | 2004-09-02 |
| CZ20031856A3 (cs) | 2003-09-17 |
| HUP0302528A2 (hu) | 2003-11-28 |
| SK8242003A3 (en) | 2004-01-08 |
| NZ525821A (en) | 2004-07-30 |
| NO20032973D0 (no) | 2003-06-27 |
| IL156138A0 (en) | 2003-12-23 |
| AR035679A1 (es) | 2004-06-23 |
| EP1351955A1 (en) | 2003-10-15 |
| JP2004520335A (ja) | 2004-07-08 |
| CN1484642A (zh) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300919A1 (ru) | N-замещенные неарильные гетероциклические антагонисты nmda/nr2b | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
| EA200400595A1 (ru) | Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы | |
| EA200401309A1 (ru) | Тризамещённые гетероарилы и способы их получения и применения | |
| EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
| EA200200546A1 (ru) | Устойчивый полиморф гидрохлорида n-(3-этинилфенил)-6,7-бис(2-метоксиэтокси)-4-хиназолинамина, способы его получения и фармацевтические применения | |
| EA200400953A1 (ru) | Замещённые пиридиноны в качестве модуляторов map-киназы p38 | |
| EA200500169A1 (ru) | Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение | |
| EA200100748A1 (ru) | Ингибиторы обратного захвата моноаминов для лечения расстройств цнс | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| EA200300528A1 (ru) | 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6 | |
| EA200400971A1 (ru) | Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения | |
| EA200500814A1 (ru) | Производные пирролопиримидина | |
| EA200400073A1 (ru) | Пирролопиримидины как ингибиторы протеинкиназы | |
| EA200300354A1 (ru) | Хинолиноновые производные в качестве ингибиторов тирозинкиназы | |
| EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
| EA200400892A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов pde4 | |
| EA200100203A1 (ru) | Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| EA200970149A1 (ru) | Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии | |
| EA200300527A1 (ru) | Новые способы лечения синдрома "усталых ног" | |
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| EA200000804A1 (ru) | Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина |